Luminex releases xPONENT 3.1 software

Launched for use on Luminex 100 and Luminex 200 systems, xPONENT 3.1 includes more than 65 new features designed to benefit scientists and laboratory professionals across research and clinical diagnostic markets in simplifying laboratory workflow and increasing productivity, the company said.

Luminex simultaneously announced that it has added xPONENT 3.1 to its FDA-cleared Luminex 100 and 200 systems for use in clinical diagnostic applications.

New features and enhancements of the xPONENT 3.1 software product line include an intuitive navigation structure, touch-screen capability, intra-well normalization function, advanced data analysis tools and an enhanced database and underlying data management architecture, according to Luminex.

For laboratories working under the FDA’s 21 CFR part 11 regulations, xPONENT software offers multilevel user management, full audit trail electronic records and electronic signatures, the company said. The software can be included in integrated systems interfaced with laboratory information systems and front-end automation platforms. It has been designed to support both carboxylated and magnetic bead applications, the company added.

Patrick Balthrop, president and CEO of Luminex, said: “xPONENT 3.1 is an innovative and exciting software upgrade for Luminex’s partners and customers, as it provides a range of new tools to help scientists work more efficiently and effectively. Furthermore, adding the new software to our FDA-cleared multiplexing system allows our partners and customers in the diagnostics field to upgrade their laboratories.”